The NEONATAL G-6-PD Screening Fluo device uses fluorescence detection to quantify the activity of the enzyme Glucose-6-Phosphate Dehydrogenase (G-6-PD) as part of the newborn screening for G6PD deficiency. This test is designed to be performed blood samples from newborns dried on 903 or 226 filter paper.
The NEONATAL MSUD Screening Fluo is an enzymatic test which enables the fluorescence detection of 3 amino acids accumulated in case of leucinosis (maple syrup urine disease - MSUD) in newborns. This test allows the quantitative determination of the amino acids leucine, isoleucine and valine from a drop of blood taken on blotting paper type 903® and 226.
The NEONATAL PKU Screening Fluo is an enzymatic test designed to screen newborns affected by phenylketonuria. This device allows the fluorescence determination of the quantity of phenylalanine presents in a drop of blood dried on 903® or 226 blotting paper.
The NEONATAL T-GAL Screening Fluo is an enzymatic test for the fluorescence detection of galactose and galactose-1-phosphate in the context of neonatal screening for galactosemia. This quantitative test is performed from a drop of blood dried on blotting paper type 903® and 226.
